In a comprehensive longitudinal analysis published in The Lancet Regional Health – Europe, researchers from the University of Liverpool have brought to light persistent and widening inequalities in childhood pneumococcal conjugate vaccine (PCV) uptake across England following a significant national immunisation schedule change. This investigation spans over a decade of vaccination data and reveals crucial insights into how alterations in vaccine schedules can have uneven impacts on different socio-economic groups, thereby influencing health equity on a population scale.
In January 2020, England transitioned its PCV immunisation schedule from a ‘2+1’ regimen—two primary doses administered at 8 and 16 weeks followed by a booster at 12 months—to a streamlined ‘1+1’ schedule that consists of a single primary dose at 12 weeks and a booster at 12 months. While this adjustment aimed to maintain immunogenic efficacy and optimize resource allocation, the longitudinal study conducted by interdisciplinary experts indicates that booster dose retention has significantly slipped since the schedule alteration.
The research team engaged in an exhaustive evaluation of vaccine uptake trends using data drawn from the Cover of Vaccination Evaluated Rapidly (COVER) program, which gathers comprehensive quarterly and annual vaccination coverage statistics for children aged 1, 2, and 5 years throughout England. Their analysis covered data from 2013 to 2025, thereby encompassing periods before and after the PCV schedule adjustment, as well as the onset of the COVID-19 pandemic.
One of the more alarming findings is the uneven decline in PCV booster uptake, with the most profound drops observed in infants residing in more socioeconomically deprived areas. By linking vaccine coverage data with the 2019 Index of Multiple Deprivation quintiles at the level of upper-tier local authorities, the researchers uncovered a stark gradient: children in the most disadvantaged communities are disproportionately missing out on booster doses, potentially exposing them to increased risk of invasive pneumococcal diseases such as pneumonia and meningitis.
This deterioration in vaccine uptake coincided chronologically with the emergence of the COVID-19 pandemic, a period marked by substantial disruption to routine healthcare services. However, the study’s data-driven approach emphasizes that the pandemic effect alone cannot fully account for the persistent and worsening disparities, highlighting systemic barriers that transcend temporary crises. Factors such as variable access to healthcare facilities, differences in health literacy, and social determinants of health continue to undermine equitable vaccine delivery.
Complementing earlier reports from the UK Health Security Agency’s National Immunisation Programme Health Equity Audit 2025 and research published in the BMJ, these results reinforce the troubling narrative that immunisation inequity within England is an entrenched, escalating public health challenge. The findings underscore the urgent need for targeted interventions designed to bridge gaps in vaccine uptake, particularly focusing on deprived populations most vulnerable to pneumococcal infections.
Given that the ‘1+1’ schedule reduces the number of clinic visits required for completion, one might expect improvements in vaccination accessibility and compliance. Paradoxically, the study reveals that fewer required visits do not alleviate the systemic obstacles faced by marginalized groups. This suggests that vaccine schedule simplification alone is insufficient without concurrent enhancements in outreach, community engagement, and flexible delivery options attuned to local contextual needs.
The implications of these findings reach beyond immediate public health outcomes; the widening immunisation gap threatens to exacerbate health inequalities and impose avoidable disease burdens on disadvantaged communities. This grows increasingly concerning in light of the House of Lords Childhood Vaccinations Committee’s ongoing inquiry into declining vaccination coverage and strategies to reverse these trends, positioning the study’s insights as a timely resource to inform policy development.
Dr. Edward Hill, corresponding author, stresses the critical importance of leveraging granular, geographically stratified data to unveil hidden vulnerabilities that aggregate national statistics often obscure. This precision-focused approach is pivotal for implementing bespoke public health interventions that efficiently mobilize resources where they are most needed.
Lead author Praise Ilechukwu highlights that while the shift to the ‘1+1’ PCV schedule was grounded in robust immunological evidence, the benefits of this rationalized schedule are yet to be equitably shared. The persistent lag in vaccination coverage within deprived areas risks leaving children therein dangerously susceptible to serious pneumococcal diseases, illustrating the interaction between vaccine policy and social determinants of health.
Co-author Professor Neil French advocates for institutionalizing routine monitoring of booster dose retention with stratification by deprivation and location as a critical performance indicator for the national vaccination programme. Such ongoing surveillance would enable early detection of emergent coverage gaps, permitting swift, targeted responses before health disparities entrench further.
Dr. Dan Hungerford further calls for comprehensive strategies that encompass the broader social determinants contributing to child health inequalities. Addressing structural factors—such as expanding access through flexible clinic hours and integrating culturally tailored community outreach—is essential to ensuring that immunisation protection is universally achieved irrespective of socioeconomic background.
Funded by the NIHR Health Protection Research Unit in Emerging and Zoonotic Infections, this rigorous data-driven study pinpoints the unintended consequences of strategic policy shifts within vaccination programmes and advances the dialogue on combating entrenched health inequities through evidence-based, equity-focused public health frameworks.
Subject of Research: People
Article Title: Inequalities in childhood pneumococcal conjugate vaccine uptake in England before and after the change from a 2+1 to 1+1 schedule: a longitudinal study
News Publication Date: 1 April 2026
Web References:
BMJ Article on Immunisation Inequity
UK House of Lords Childhood Vaccinations Committee Inquiry
References: The Lancet Regional Health – Europe (2026), University of Liverpool Research
Keywords: Vaccination, Vaccine research, Viral infections, Pneumonia, Immunisation inequity, Pneumococcal Conjugate Vaccine, Public health, Health inequalities, Child health, Vaccine uptake, COVID-19 impact, Health equity audit
Tags: 2+1 versus 1+1 vaccine schedule comparisonbooster dose retention rates Englandchildhood pneumococcal vaccine uptake inequalitiesCOVER program vaccine data Englandhealth equity in childhood immunisationimpact of immunisation schedule on public healthlongitudinal analysis of vaccine uptakePCV immunisation schedule revision impactpneumococcal conjugate vaccine schedule change Englandresource allocation in childhood vaccination programssocioeconomic disparities in vaccine coveragevaccination coverage trends children England
